Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 225

1.

Chemoprevention of tocotrienols: the mechanism of antiproliferative effects.

Wada S.

Forum Nutr. 2009;61:204-16. doi: 10.1159/000212752. Review.

PMID:
19367124
2.

Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.

McAnally JA, Gupta J, Sodhani S, Bravo L, Mo H.

Exp Biol Med (Maywood). 2007 Apr;232(4):523-31.

PMID:
17392488
3.

Tumor suppressive effects of tocotrienol in vivo and in vitro.

Wada S, Satomi Y, Murakoshi M, Noguchi N, Yoshikawa T, Nishino H.

Cancer Lett. 2005 Nov 18;229(2):181-91.

PMID:
16098658
4.
5.

Mechanisms mediating the antiproliferative and apoptotic effects of vitamin E in mammary cancer cells.

Sylvester PW, Shah SJ.

Front Biosci. 2005 Jan 1;10:699-709. Review.

PMID:
15569611
6.

Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells.

McIntyre BS, Briski KP, Gapor A, Sylvester PW.

Proc Soc Exp Biol Med. 2000 Sep;224(4):292-301.

PMID:
10964265
7.

Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway.

Shin-Kang S, Ramsauer VP, Lightner J, Chakraborty K, Stone W, Campbell S, Reddy SA, Krishnan K.

Free Radic Biol Med. 2011 Sep 15;51(6):1164-74. doi: 10.1016/j.freeradbiomed.2011.06.008.

PMID:
21723941
8.

Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling.

Packer L, Weber SU, Rimbach G.

J Nutr. 2001 Feb;131(2):369S-73S. Review.

9.

The 21st century form of vitamin E--tocotrienol.

Bardhan J, Chakraborty R, Raychaudhuri U.

Curr Pharm Des. 2011;17(21):2196-205. Review.

PMID:
21774783
10.

Tocotrienols and cardiovascular health.

Prasad K.

Curr Pharm Des. 2011;17(21):2147-54. Review.

PMID:
21774782
11.

Tocotrienol as a potential anticancer agent.

Ling MT, Luk SU, Al-Ejeh F, Khanna KK.

Carcinogenesis. 2012 Feb;33(2):233-9. doi: 10.1093/carcin/bgr261. Review.

PMID:
22095072
12.

Multitargeted therapy of cancer by tocotrienols.

Nesaretnam K.

Cancer Lett. 2008 Oct 8;269(2):388-95. doi: 10.1016/j.canlet.2008.03.063. Review.

PMID:
18504069
13.

[Progression of tocotrienols].

Sun W, Yan Y, Dong F.

Wei Sheng Yan Jiu. 2004 Mar;33(2):243-5. Review. Chinese.

PMID:
15209019
14.

Cancer preventive effects of vitamin E.

Wada S.

Curr Pharm Biotechnol. 2012 Jan;13(1):156-64. Review.

PMID:
21466429
15.

Tocotrienols suppress proinflammatory markers and cyclooxygenase-2 expression in RAW264.7 macrophages.

Yam ML, Abdul Hafid SR, Cheng HM, Nesaretnam K.

Lipids. 2009 Sep;44(9):787-97. doi: 10.1007/s11745-009-3326-2.

PMID:
19655189
16.

d-δ-Tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa-2, and BxPC-3 pancreatic carcinoma cells.

Hussein D, Mo H.

Pancreas. 2009 May;38(4):e124-36. doi: 10.1097/MPA.0b013e3181a20f9c.

PMID:
19346993
17.

gamma-Tocotrienol induces mitochondria-mediated apoptosis in human gastric adenocarcinoma SGC-7901 cells.

Sun W, Xu W, Liu H, Liu J, Wang Q, Zhou J, Dong F, Chen B.

J Nutr Biochem. 2009 Apr;20(4):276-84. doi: 10.1016/j.jnutbio.2008.03.003.

PMID:
18602811
18.

Tocotrienol inhibits proliferation of human Tenon's fibroblasts in vitro: a comparative study with vitamin E forms and mitomycin C.

Meyenberg A, Goldblum D, Zingg JM, Azzi A, Nesaretnam K, Kilchenmann M, Frueh BE.

Graefes Arch Clin Exp Ophthalmol. 2005 Dec;243(12):1263-71.

PMID:
15909162
19.

Tocotrienols inhibit human glutathione S-transferase P1-1.

van Haaften RI, Haenen GR, Evelo CT, Bast A.

IUBMB Life. 2002 Aug;54(2):81-4.

20.

Cellular protection and therapeutic potential of tocotrienols.

Catalgol B, Batirel S, Ozer NK.

Curr Pharm Des. 2011;17(21):2215-20. Review.

PMID:
21774780

Supplemental Content

Support Center